Completed NA INTERVENTIONAL 1-arm NCT05688826

The Effect of Sugar Load in IBS Patients Depending on Sucrase-isomaltase Genes

Comparison of Sugar Load Between Normal and Functional Variants of Sucrase-isomaltase Genes in IBS

Sponsor: Region Skane

Conditions Irritable Bowel Syndrome Sucrase-Isomaltase Deficiency

Interventions Sugar

Updated 6 times since 2023 Last updated: Jun 23, 2025 Started: Jan 4, 2023 Primary completion: Sep 27, 2023 Completion: Jun 23, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Irritable Bowel Syndrome and Sucrase-Isomaltase Deficiency, this trial is completed. The trial is conducted by Region Skane and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Jul 2025 — Sep 2025 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Sep 2024 — Jul 2025 [monthly]

Enrolling By Invitation NA
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation NA
May 2024 — Jul 2024 [monthly]

Enrolling By Invitation NA

▶ Show 1 earlier version

Feb 2023 — May 2024 [monthly]

Enrolling By Invitation NA

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Region Skane

Data source: Region Skane

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malmo, Sweden